{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:33:01Z","timestamp":1790087581014,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.canlet.2019.02.017","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T16:40:06Z","timestamp":1550076006000},"page":"128-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Diabetes and cancer: Debating the link through Ca2+\/cAMP signalling"],"prefix":"10.1016","volume":"448","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7432-9958","authenticated-orcid":false,"given":"Leandro Bueno","family":"Bergantin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.02.017_bib1","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00125-018-4664-5","volume":"61","author":"Ohkuma","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.canlet.2019.02.017_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050048","article-title":"Targeting intracellular calcium signaling ([Ca2+]i) to overcome acquired multidrug resistance of cancer cells: a mini-overview","volume":"9","author":"Busselberg","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2019.02.017_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.lfs.2010.09.013","article-title":"Calcium wave signaling in cancer cells","volume":"87","author":"Parkash","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2019.02.017_bib4","doi-asserted-by":"crossref","first-page":"31666","DOI":"10.1074\/jbc.R112.343061","article-title":"Calcium channels and pumps in cancer: changes and consequences","volume":"287","author":"Monteith","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.02.017_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1574892811308010027","article-title":"Targeting calcium channels to block tumor vascularization","volume":"8","author":"Munaron","year":"2013","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.canlet.2019.02.017_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00109-014-1235-1","article-title":"NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1alpha signal transduction","volume":"93","author":"Kim","year":"2015","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.canlet.2019.02.017_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bcp.2006.12.011","article-title":"G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells","volume":"73","author":"Yoshida","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.02.017_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/adt.2015.29014.ajkdrrr","article-title":"Repurposing and rescuing of mibefradil, an antihypertensive, for cancer: a case study","volume":"13","author":"Krouse","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"issue":"4","key":"10.1016\/j.canlet.2019.02.017_bib9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/db11-0955","article-title":"Preventing beta-cell loss and diabetes with calcium channel blockers","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.canlet.2019.02.017_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diabres.2016.01.021","article-title":"Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study","volume":"115","author":"Yulia","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.canlet.2019.02.017_bib11","first-page":"1","article-title":"Ca2+and camp: do these intracellular messengers \u2018work\u2019 independently? Of course not, and the history goes ahead","volume":"7","author":"Bergantin","year":"2017","journal-title":"J. Clin. Exp. Oncol."},{"issue":"1\u20133","key":"10.1016\/j.canlet.2019.02.017_bib12","first-page":"1","article-title":"New antitumoral pharmacological strategies involving Ca2+\/cAMP signaling pathways","volume":"2","author":"Errante","year":"2017","journal-title":"J. Canc. Epidemiol. Prev."},{"issue":"1","key":"10.1016\/j.canlet.2019.02.017_bib13","first-page":"1","article-title":"Insights for the inhibition of cancer progression: revisiting Ca2+ and cAMP signalling pathways","volume":"2","author":"Errante","year":"2017","journal-title":"Adv. Canc. Prev."},{"issue":"4","key":"10.1016\/j.canlet.2019.02.017_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2324-9110.1000e111","article-title":"The pharmacological modulation of Ca2+\/cAMP intracellular signaling pathways and traditional antitumoral pharmaceuticals: a plausible multitarget combined therapy?","volume":"6","author":"Errante","year":"2017","journal-title":"J. Clin. Exper. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2019.02.017_bib15","first-page":"1","article-title":"The second messengers Ca2+ and cAMP as potential therapeutic targets for the control of cancer progression","volume":"2","author":"Errante","year":"2017","journal-title":"Adv. Canc. Prev."},{"issue":"3","key":"10.1016\/j.canlet.2019.02.017_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ceca.2013.06.004","article-title":"Novel model for \"calcium paradox\" in sympathetic transmission of smooth muscles: role of cyclic AMP pathway","volume":"54","author":"Bergantin","year":"2013","journal-title":"Cell Calcium"},{"key":"10.1016\/j.canlet.2019.02.017_bib17","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4158\/EP10357.RA","article-title":"Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Noto","year":"2011","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.canlet.2019.02.017_bib18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2019.02.017_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejca.2011.07.010","article-title":"Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences","volume":"48","author":"Kramer","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2019.02.017_bib20","series-title":"Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective [article Online]","year":"2007"},{"key":"10.1016\/j.canlet.2019.02.017_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ajcn\/87.3.627","article-title":"Glycemic index, glycemic load, and chronic disease risk\u2013a meta-analysis of observational studies","volume":"87","author":"Barclay","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.canlet.2019.02.017_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3322\/canjclin.56.5.254","volume":"56","author":"Kushi","year":"2006","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.canlet.2019.02.017_bib23","series-title":"Exercise and Diabetes","first-page":"231","article-title":"Nutritional management of diabetes in diabetes and exercise","author":"Tomuta","year":"2009"},{"key":"10.1016\/j.canlet.2019.02.017_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/157339909789804341","article-title":"Dietary patterns and prevention of type 2 diabetes: from research to clinical practice; a systematic review","volume":"5","author":"Kastorini","year":"2009","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.canlet.2019.02.017_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/613268","article-title":"Mango fruit extracts differentially affect proliferation and intracellular calcium signalling in MCF-7 human breast cancer cells","volume":"2015","author":"Taing","year":"2015","journal-title":"J. Chem."},{"key":"10.1016\/j.canlet.2019.02.017_bib26","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.02.017_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cc.8.6.7933","article-title":"Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro","volume":"8","author":"Alimova","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2019.02.017_bib28","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4161\/cc.8.13.8814","article-title":"Metformin induces unique biological and molecular responses in triple negative breast cancer cells","volume":"8","author":"Liu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2019.02.017_bib29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1677\/ERC-08-0038","article-title":"Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth","volume":"15","author":"Algire","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2019.02.017_bib30","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4161\/cc.8.10.8406","article-title":"Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, auroras and polo-like kinases] M-phase cell cycle genes in human breast cancer cells","volume":"8","author":"Oliveras-Ferraros","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2019.02.017_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cc.8.1.7499","article-title":"The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells","volume":"8","author":"Vazquez-Martin","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2019.02.017_bib32","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.02.017_bib33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exger.2005.07.007","article-title":"Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2\/neu transgenic mice","volume":"40","author":"Anisimov","year":"2005","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.canlet.2019.02.017_bib34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.02.017_bib35","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","article-title":"Obesity and cancer: the role of dysfunctional adipose tissue","volume":"18","author":"van Kruijsdijk","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canlet.2019.02.017_bib36","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2019.02.017_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.02.017_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature07782","article-title":"Tumours with PI3K activation are resistant to dietary restriction","volume":"458","author":"Kalaany","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.02.017_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cmet.2009.04.006","article-title":"Do cancer cells care if their host is hungry?","volume":"9","author":"Pollak","year":"2009","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2019.02.017_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejphar.2016.06.034","article-title":"Challenges for the pharmacological treatment of neurological and psychiatric disorders: implications of the Ca2+\/cAMP intracellular signalling interaction","volume":"788","author":"Bergantin","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2019.02.017_bib41","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.4172\/2168-975X.1000e125","article-title":"Neurodegenerative diseases: where to go from now? Thought provoking through Ca2+\/cAMP signaling interaction","volume":"6","author":"Bergantin","year":"2017","journal-title":"Brain Disord. Ther."},{"key":"10.1016\/j.canlet.2019.02.017_bib42","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.4172\/2329-6895.1000e124","article-title":"Neurological disorders: is there a horizon? Emerging ideas from the interaction between Ca2+ and camp signaling pathways","volume":"5","author":"Bergantin","year":"2017","journal-title":"J Neurol Disord"},{"issue":"5","key":"10.1016\/j.canlet.2019.02.017_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.181","article-title":"Pharmacological implications of the Ca2+\/cAMP signaling interaction: from risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disorders","volume":"3","author":"Caricati-Neto","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"9","key":"10.1016\/j.canlet.2019.02.017_bib44","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of alzheimer's disease","volume":"31","author":"Mattson","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.canlet.2019.02.017_bib45","doi-asserted-by":"crossref","DOI":"10.15761\/JSIN.1000185","article-title":"Pharmacological modulation of neural Ca2+\/camp signaling interaction as therapeutic goal for treatment of Alzheimer's disease","volume":"3","author":"Caricati-Neto","year":"2017","journal-title":"J Syst Integr Neurosci"},{"key":"10.1016\/j.canlet.2019.02.017_bib46","doi-asserted-by":"crossref","DOI":"10.15761\/JSIN.1000186","article-title":"The passion of a scientific discovery: the \u201ccalcium paradox\u201d due to Ca2+\/camp interaction","volume":"3","author":"Caricati-Neto","year":"2017","journal-title":"J Syst Integr Neurosci"},{"key":"10.1016\/j.canlet.2019.02.017_bib47","article-title":"From a \u201ceureka insight\u201d to a novel potential therapeutic target to treat Parkinson's disease: the Ca2+\/camp signalling interaction","volume":"4","author":"Caricati-Neto","year":"2017","journal-title":"J Syst Integr Neurosci"},{"key":"10.1016\/j.canlet.2019.02.017_bib48","article-title":"Hypertension, diabetes and neurodegenerative diseases: is there a clinical link through the Ca2+\/cAMP signalling interaction?","author":"Bergantin","year":"2018","journal-title":"Curr. Hypertens. Rev."},{"issue":"6","key":"10.1016\/j.canlet.2019.02.017_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0898-6568(97)00178-2","article-title":"Divergence and convergence in regulated exocytosis: the characteristics of cAMP-dependent enzyme secretion of parotid salivary acinar cells","volume":"10","author":"Fujita-Yoshigaki","year":"1998","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.canlet.2019.02.017_bib50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/03009734.2012.724732","article-title":"Cyclic AMP dynamics in the pancreatic \u03b2-cell","volume":"117","author":"Anders","year":"2012","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.canlet.2019.02.017_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2006.10.017","article-title":"The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor","volume":"127","author":"Gomez-Ospina","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.02.017_bib52","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.bbamem.2015.03.034","article-title":"Targeting ion channels for cancer therapy by repurposing the approved drugs","volume":"1848","author":"Kale","year":"2015","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.canlet.2019.02.017_bib53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00424-014-1444-z","article-title":"T-type calcium channels blockers as new tools in cancer therapies","volume":"466","author":"Dziegielewska","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.canlet.2019.02.017_bib54","first-page":"267","article-title":"T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells","volume":"41","author":"Ohkubo","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2019.02.017_bib55","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1074\/jbc.M707159200","article-title":"CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells","volume":"283","author":"Gacki\u00e8re","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.02.017_bib56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/glia.20063","article-title":"Expression of T-type calcium channel splice variants in human glioma","volume":"48","author":"Latour","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.canlet.2019.02.017_bib57","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1517\/14728222.2013.798304","article-title":"Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma","volume":"17","author":"Murray","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2019.02.017_bib58","article-title":"Cancer and hypertension: debating the clinical link through the Ca2+\/cAMP signaling","volume":"3","author":"Bergantin","year":"2018","journal-title":"Glob Vaccines Immunol"},{"key":"10.1016\/j.canlet.2019.02.017_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.01.008","article-title":"Debating the \u201cbidirectional link\u201d between diabetes and depression through the Ca2+\/cAMP signalling: off-label effects of Ca2+ channel blockers","author":"Bergantin","year":"2019","journal-title":"Pharmacol. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519300898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519300898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T19:27:14Z","timestamp":1720985234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519300898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":59,"alternative-id":["S0304383519300898"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.02.017","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and cancer: Debating the link through Ca2+\/cAMP signalling","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}